

8%
Dec' 15 | Dec' 16 | Dec' 17 | Dec' 18 | Dec' 19 | Dec' 20 | Dec' 21 | Dec' 22 | Dec' 23 | Dec' 24 | YTD | |
---|---|---|---|---|---|---|---|---|---|---|---|
NAV(₹) | - | - | - | - | - | - | 10.27 | 9.37 | 12.34 | 17.43 | 14.84 |
AUM(Cr.) | - | - | - | - | - | - | 179.31 | 152.30 | 143.28 | 230.79 | 200.83 |
Benchmark# BM# Returns(%) | - | - | - | - | - | - | 2.38 | 3.02 | 25.77 | 15.16 | -9.83 |
Fund Returns(%) ⓘ | - | - | - | - | - | - | 4.05 | -8.76 | 31.70 | 41.25 | -14.86 |
Implied Investor Returns(%) IR(%) | - | - | - | - | - | - | 122.58 | -11.98 | 26.62 | 46.29 | -64.94 |
Alpha(%) (Returns over Benchmark) | - | - | - | - | - | - | 1.67 | -11.78 | 5.93 | 26.09 | -5.03 |
Expense Ratio(%) | - | - | - | - | - | - | 2.54 | 2.37 | 2.34 | 2.35 | 2.35 |
9 Year | 5 Year | 3 Year | 1 Year | |
---|---|---|---|---|
Benchmark# BM# Returns(%) | - | - | 11.59 | -0.7 |
Fund Returns(%) | - | - | 16.8 | 7.68 |
Implied Investor Returns(%) IR | - | - | 12.72 | 5.25 |
ITI Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care with an 201(Cr) AUM. It is Open Ended scheme launched on 08 Nov 2021. Currently, Rohan Korde and Dhimant Shah as the fund managers managing the fund. Benchmark of the scheme is Nifty Healthcare Index - TRI.
1 Year | 3 Year | 5 Year | 9 Year | |
---|---|---|---|---|
Upside % | 122 | 104 | - | - |
Downside % | 30 | 34 | 28 | 32 |
Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
---|---|---|---|---|---|---|
Fund | 0.00% | 0.88 | -0.01 | -0.02 | 0.59 | -5.03% |
Benchmark# | 0.05% | 0.97 | 0.03 | 0.05 | 0.59 | - |
Average Rolling Return | Standard Deviation | |||||||
---|---|---|---|---|---|---|---|---|
1 Year | 3 Year | 5 Year | 9 Year | 1 Year | 3 Year | 5 Year | 9 Year | |
Fund | 28.07 | 17.03 | 0.00 | 0.00 | 22.28 | 2.74 | 0.00 | 0.00 |
Benchmark# | 21.90 | 12.70 | 0.00 | 0.00 | 15.43 | 2.10 | 0.00 | 0.00 |
Company (Q) | Sector | % Assets |
---|---|---|
Healthcare | 15.86 | |
Healthcare | 6.26 | |
Healthcare | 6.06 | |
Healthcare | 5.67 | |
Healthcare | 5.02 | |
Healthcare | 4.65 | |
Healthcare | 4.23 | |
Healthcare | 4 | |
Healthcare | 3.35 | |
Healthcare | 2.95 |
Launch Date | 08 Nov 2021 |
Benchmark | Nifty Healthcare Index - TRI |
Performance comparison Benchmark# | NIFTY 500 |
Riskometer | Very High |
Turnover | 0.62% |
Type | Open ended scheme |
Return Since Launch | 12.49% |
Min. Investment | 5000.00 |
Min. Additional investment Min. Add. inv. | 1000.00 |
Min. SIP | 500.00 |
Min. Cheques | 12 |
Min. Withdrawal | 1000.00 |
Exit Load | 1.00% |
Remark | 1% on or before 12M, Nil after 12M |
ITI Pharma & Healthcare Fund - Regular Plan - Growth has delivered CAGR and average rolling returns as follows :
1 Year | 3 Year | 5 Year | 9 Year | |
CAGR(%) | 7.68 | 16.8 | N/A | N/A |
Average Rolling Returns(%) | 28.07 | 17.03 | N/A | N/A |
The Current NAV of ITI Pharma & Healthcare Fund - Regular Plan - Growth is ₹14.84.
It is better to invest in a fund with a longer track record as ITI Pharma & Healthcare Fund - Regular Plan - Growth cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.
ITI Pharma & Healthcare Fund - Regular Plan - Growth fund’s expense ratio is 2.35%
The process for redemption is
The AUM of ITI Pharma & Healthcare Fund - Regular Plan - Growth is currently ₹201 Crores.
The Top three stocks are Sun Pharma Inds., Lupin and Suven Pharma and account for 28% of its portfolio. Top 5 and 10 stocks of fund account for 39% and 58% of fund’s portfolio respectively.
Top three sectors of ITI Pharma & Healthcare Fund - Regular Plan - Growth fund are Healthcare, Miscellaneous and Chemicals accounting for 99% of the total portfolio.
Funds Portfolio Quality is Somewhat Good. It has a large proportion of Green and Orange Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of ITI Pharma & Healthcare Fund - Regular Plan - Growth Fund is Equity - Sectoral Fund - Pharma & Health Care.
Rohan Korde and Dhimant Shah manage the ITI Pharma & Healthcare Fund - Regular Plan - Growth Fund.
ITI Pharma & Healthcare Fund - Regular Plan - Growth current PE ratio is 48.97 and PB ratio is 7.13
The asset allocation of ITI Pharma & Healthcare Fund - Regular Plan - Growth is Stocks : 97.88%, Debt : 2.15% and Gold : 0%
The minimum SIP amount for ITI Pharma & Healthcare Fund - Regular Plan - Growth is ₹500.00 and minimum lumpsum is ₹5000.00
The exit load for ITI Pharma & Healthcare Fund - Regular Plan - Growth is 1% on or before 12 months, Nil after 12 months